Background: Endobronchial ultrasound (EBUS) procedures tend to be longer than routine bronchoscopies. Increased duration and sedative dosing put patients at increased risk for hypoxic events. Objective: To determine whether oxygen supplementation via a nasal trumpet connected to a Mapleson B circuit (NTM) was effective in decreasing hypoxic events when compared with the standard of care, oxygen supplementation with a nasal cannula (NC). 
Introduction
Procedure durations for endobronchial ultrasound with transbronchial needle aspiration biopsy (EBUS-TBNA) tend to be longer than those for standard bronchoscopy due (1) to the sampling at times of multiple sites and (2) to the concomitant use of rapid on-site cytology. Duration of sedation and total doses therefore tend to be greater. Both of these factors increase the risk of clinically relevant desaturation during EBUS, and at different institutions responses to this possibility have ranged from EBUS with routine bronchoscopy sedation to EBUS in the operating room (OR) with general anesthesia (GA) [1] [2] [3] . At Cooper University Hospital, we have chosen to perform EBUS in the bronchoscopy suite with monitored anesthesia care (MAC) provided by an anesthesiologist. When clinically relevant desaturation does occur, the anesthesiologist needs to control the airway. This often leads to temporary discontinuation and at times to termination of the EBUS procedure. After some initial success with the use of a nasal trumpet connected to a Mapleson circuit (NTM) to correct hypoxia occurring during EBUS with MAC, we instituted a prospective trial comparing NTM throughout the procedure with the current standard for oxygen supplementation, a nasal cannula (NC).
Methods

Subjects
The study was approved by the Cooper University Hospital Institutional Review Board (IRB #14-081). All adult patients (inpatient or outpatient) referred to interventional pulmonary for EBUS for the diagnostic workup of a mass and/or mediastinal adenopathy over the study interval were evaluated for study entry. Exclusion criteria included contraindications for bronchoscopy, uncorrectable coagulopathy, known nasal passage obstruction or severe epistaxis, history of intolerance of MAC, pregnancy, and inability to obtain informed consent. 
Study Design
This was a prospective randomized controlled study of two different approaches to oxygen supplementation during MAC for EBUS. Informed consent was obtained in all cases. Subjects have given their written informed consent to publication of images. Randomization was achieved using computer software. The control group received supplemental oxygen via an NC titrated as needed to a maximum of 10 L, our standard approach. The study group received oxygen via a Mapleson circuit connected to a nasal trumpet (NTM). Figure 1 demonstrates the NTM system in place for a procedure. Apart from modality of oxygen supplementation, all procedural details were identical for both groups.
An anesthesiologist administered MAC, monitored vital signs, and performed any airway interventions. All procedures were performed by one of two interventional pulmonologists (W.A. and Z.B.). EBUS-TBNA was performed using an Olympus bronchoscope (BF-UC-180F) and 21-gauge needles. In order to minimize procedural delays, our standard protocol involves the use of two needles for each patient. At least 3 aspirations were obtained from each target. Procedure time was defined as time from initial introduction of the bronchoscope to final withdrawal. Rapid on-site examination was available for all procedures.
The primary endpoint of the study was the number of hypoxia-related interruptions that occurred during the procedure. For this study, hypoxia was defined as a drop in saturation of 5% or more that did not self-correct. An interruption was defined as a cessation of bronchoscopist activities related to the need to intervene to improve oxygenation. Interventions included the addition of another oxygen source such as a 100% non-rebreather, a jaw-thrust maneuver to open up the upper airway, and the need for bag mask ventilation. Some interruptions included the need to completely withdraw the bronchoscope from the airway while others did not.
The protocol included a crossover pathway. Crossover from the NC group to the NTM protocol was allowed for patients under either of two conditions: (1) a patient experienced 4 or more interruptions within 5 consecutive minutes, or (2) recovery had not occurred within 2 min of an interruption. For patients who did not tolerate either arm of the study, the plan was to terminate the procedure and reschedule it in the OR under GA.
Secondary endpoints included amounts of sedatives administered, number of crossovers from the NC arm to the NTM arm, procedure time, whether or not procedure goals were achieved, status of the patient at time of discharge, and incidence of nosebleed. 
Statistical Analysis
The Mann-Whitney U test was used to determine statistical significance for the interruptions between groups. t testing and Pearson's χ
2 test were used to analyze demographics of both groups. A p value of < 0.05 was considered to be statistically significant.
Results
Between March 2016 and April 2018, 148 patients were screened for eligibility. One hundred patients met eligibility criteria and were randomized, 52 to NC and 48 to NTM. Both groups were well balanced with respect to baseline characteristics, including gender, Mallampati scores, and smoking status ( Table 1 ). The incidence of obstructive sleep apnea did not differ between groups. There was no significant difference in baseline room air oxygen saturation levels. MAC was achieved with combinations of versed, fentanyl, propofol, and ketamine. Both groups received comparable amounts of all four sedatives (see Table 1 ). Table 2 lists sites biopsied and final diagnoses. Two hundred and three lymph nodes were biopsied, 12 lung masses were accessed with the convex EBUS bronchoscope, and one left adrenal gland was biopsied with the EBUS bronchoscope introduced through the esophagus. (All patients underwent EBUS procedures, and 1 patient underwent both EBUS and esophageal ultrasound [EUS] .) Primary lung cancer was the most common diagnosis.
In the NC group, 41 out of 52 patients (79%) had interruptions, with a mean of 2.6 and a range of 1-6. In the NTM group, 1 patient (2%) had 2 interruptions, while the remaining 47 patients underwent EBUS-TBNA without any interruptions. The difference between the two groups was significant, with p < 0.001. Procedure duration was also shorter for the NTM group (27.25 ± 10.08 min) versus the NC group (31.98 ± 11.29 min), with p < 0.03.
Fourteen patients from the NC group were crossed over to NTM. Three out of the 14 were crossed over after the first interruption, as they had not recovered within 2 min of standard airway maneuvers. Three patients were crossed over after a second interruption, 6 patients after 3 interruptions, and 4 were crossed over after 4 interruptions. Once crossed over, 13 out of the 14 patients completed the procedure without any subsequent interruptions. The remaining patient had one additional interruption after crossing over to NTM, but the interruption did not prevent procedure completion. All baseline characteristics apart from gender were similar when comparing the crossover group to the group that did not cross over; 10 out of 14 (71%) of crossover patients were women, whereas 14 out of 38 (37%) in the noncrossover group were women (p = 0.026).
All patients enrolled in this study were able to complete their planned procedures; no cancellations occurred. There were no major complications directly related to the study. All patients in both arms returned to preprocedure status prior to discharge. There were no unplanned admissions, and no inpatient required escalation of care. Three minor complications occurred in this study, all nosebleeds related to insertion of the nasal trumpet. Two patients in the initial NTM group and 1 patient in the crossover group suffered from epistaxis when the nasal trumpet was inserted. One episode of epistaxis resolved spontaneously. The other two resolved after local instillation of lidocaine/epinephrine.
Discussion
Bronchoscopy and transbronchial needle aspiration biopsy using the convex curvilinear ultrasound bronchoscope (EBUS-TBNA) and, to a lesser extent, EUS and fine needle aspiration with the same bronchoscope have become established and important diagnostic tools in the hands of the interventional pulmonologist faced with mediastinal adenopathy and with masses adjacent to the airways and/or esophagus [4, 5] . EBUS procedures tend to be longer than standard bronchoscopies due to the acquisition of multiple targets when staging lung cancer and to the frequent use of on-site cytology. In addition, patients undergoing EBUS bronchoscopy for suspected lung cancer often have coexisting comorbidities such COPD [6] , making them more prone to intraprocedural hypoxic episodes. Because of these issues, there has been an ongoing discussion about optimal procedure location and sedation modalities for EBUS, ranging from EBUS in the bronchoscopy suite with standard moderate sedation to EBUS in the bronchoscopy suite with MAC administered by an anesthesiologist to EBUS in the OR with GA [1] [2] [3] . The first two require spontaneous ventilation, increase the risk of hypoxemia, and may need to have the procedure terminated for airway control when adverse events do occur. EBUS in the OR with GA allows better control of oxygenation but involves the use of a laryngeal mask airway or an endotracheal tube. Both
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www.karger.com/bmh significantly limit the lumen available for bronchoscopy, a potential problem, and EUS cannot be performed with a laryngeal mask airway in place. In addition, GA in the OR incurs significantly higher costs with no ostensible increase in yield or patient satisfaction [2, 3, 7] . MAC has been used for years for gastrointestinal endoscopy, with a relatively large body of related literature. At our institution, MAC is now the standard of care for anesthesia when performing EBUS.
Hypoxia is probably the most common complication of bronchoscopy; a definitive statement is difficult, as the literature varies markedly with respect to the definition and documentation of hypoxia. A recent extensive review lists hypoxia as a complication in 0.7-76.3% of cases, a huge range that more likely reflects definition and documentation than true differences in incidence [8] . Two studies that looked specifically at rates of desaturation with EBUS under MAC yielded rates of 36 and 45% [1, 9] .
The best argument for EBUS in the OR is that it affords better airway control (despite the issues involved) and is more effective in preventing respiratory decompensations and the need for procedure interruption. In this prospective study, we have demonstrated that the NTM system can allow effective completion of EBUS under MAC in the bronchoscopy suite with a very low incidence of hypoxic events; events occurred in 2% of patients in the NTM group. If one adds to the NTM group those patients crossed over to NTM, events occurred in 4% of NTM patients. Both of these are far lower than the rates of 36 and 45% cited above [1, 9] . The decreased incidence of hypoxic events and thus of interruptions translated directly into increased efficiency in the form of decreased procedure durations. One can conclude based upon these study data that with the use of NTM most patients can be safely and efficiently diagnosed in the bronchoscopy suite.
Sedation-induced hypoxia is related to two main phenomena: (1) central depression of respiratory drive, and (2) upper airway obstruction caused by relaxation of the velopharyngeal muscles and the tongue [10, 11] . (During bronchoscopy, these factors are potentially exacerbated by airway obstruction caused by the bronchoscope, suctioning of inspired gasses, and instillation of fluids into the airways.) Insertion of a nasal trumpet allows bypass of the upper airway obstruction (see Fig. 2 ), and the use of a Mapleson circuit allows the anesthesiologist to increase both flow and inspired FIO 2 . The efficacy of NTM as an intervention documented in this study leads one to conclude that upper airway collapse is the dominant mechanism of hypoxemia with levels of sedation up to and including MAC. A Mapleson circuit is a breathing circuit that is an assembly of components; it includes a reservoir bag, corrugated tubing, and an adjustable pressure-limiting valve (see Fig. 3 ). This circuit connects the patient's airway to fresh gas flow (oxygen in this study) and allows spontaneous, assisted, or controlled respiration. It is lightweight, inexpensive, and simple to use. At our hospital the cost of a Mapleson B circuit is USD 4.86. During spontaneous inspiration, oxygen flows from the oxygen source and reservoir to the patient. During expiration, initial expiratory flow fills the corrugated tubing and interrupts the forward flow of gasses. This allows the reservoir to refill. When the reservoir bag is full, the adjustable expiratory valve opens and vents remaining expired gas into the atmosphere. With inspiration, the vent closes. Inspired gas includes the gas in the tubing, gas from the reservoir, and gas flowing directly from the oxygen source. Whereas initial exhaled gas consisted of dead space ventilation which had not participated in gas exchange, all inspired gasses contain 100% oxygen [12] . Performance of the circuit and classification are determined by the location of the components in the Mapleson circuit. We used the Mapleson B circuit in this study as that is the circuit available in our institution. The Mapleson B system features the fresh gas inlet near the patient, distal to the expiratory valve. Typically, Mapleson circuits are attached either to a face mask or to an endotracheal tube. Different from conventional practice, in our study the Mapleson circuit was connected to a nasal trumpet. The distal end of the nasal trumpet sat above the vocal cords, delivering high-flow oxygen and assisting in removal of exhaled CO 2 while the patient was breathing spontaneously (Fig. 4) . Goudra et al. [11] have previously described the use of NTM during gastrointestinal endoscopy, but their account is anecdotal; we are unaware of any published series in that literature. To our knowledge, this report represents the first published series and the first report of the use of an NTM system for bronchoscopy.
This study was notable for a very high incidence of hypoxia in the NC group, with interruptions occurring in 79% (41 out of 52). This rate is higher than many previously reported rates [1, 8, 9] . The rate may be due to the fact that a combination of 4 different sedatives was used in our study. However, there was no difference in sedatives administered when comparing both groups. End-tidal carbon dioxide was not used as a parameter in this study because even though it was monitored, we were unsure of the accuracy of the numbers given the high fresh gas flow used with the Mapleson circuit.
The main limitation of the study is the fact that it was not blinded to the operators, as this was not possible. In order to try to eliminate operator bias, we clearly defined desaturation episodes, allowed time for self-correction of transient hypoxias, and, more importantly, clearly defined the airway interventions and maneuvers that led to interruption of a bronchoscopy.
In summary, the use of a Mapleson circuit with nasal trumpet is a simple, safe, and effective way to provide supplemental oxygen during EBUS and to significantly decrease the incidence of hypoxia and the associated procedural interruptions. While this study was confined to EBUS with MAC, there is no reason why NTM cannot be applied to bronchoscopy with conscious sedation or MAC performed on any patient deemed at high risk for hypoxia; known sleep apnea, morbid obesity, severe COPD, and anticipation of a prolonged procedure might be reasonable criteria for the preemptive use of NTM.
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